Director & PDMR Share Purchases

24th August 2021 - 12:02 pm

ImmuPharma PLC (LSE:IMM) (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company, announces that each member of the Board of Directors and PDMR, Ewa Flynn (Chief Financial Officer) have on 23 & 24 August 2021 purchased in total 670,000 ordinary shares of 10p in the Company (“Ordinary Shares”).

Details of the share purchases by the Board and their current interests in shares following the transactions are set out below.

Full disclosure of the transactions by persons discharging managerial responsibilities and persons closely associated with them (“PDMR’s”) are detailed in the full announcement: download here

Share this article